---
title: "Modern Chinese Medicine Details Highly Concentrated Insider Shareholding"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283182481.md"
description: "Modern Chinese Medicine Group Co. Ltd. (HK:1643) has announced a high concentration of shareholding, revealing key shareholders. Modern Biotechnology Group Holdings, owned by chairlady Sun Xinlei, holds 55.8% of shares, while Universal Health (Global) Investment Fund Management, owned by Chen Xiaoyan, holds 16.7%. This concentrated ownership structure indicates limited free float and potential liquidity issues for minority investors. The company, listed in Hong Kong, focuses on modernized traditional Chinese medicine products and has a market cap of HK$1.86B."
datetime: "2026-04-17T15:08:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283182481.md)
  - [en](https://longbridge.com/en/news/283182481.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283182481.md)
---

# Modern Chinese Medicine Details Highly Concentrated Insider Shareholding

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ) just unveiled an announcement.

Modern Chinese Medicine Group Co., Ltd. has issued a supplemental announcement regarding a high concentration of its shareholding, clarifying the identities of key shareholders previously unnamed. The filing shows that Modern Biotechnology Group Holdings, wholly owned by chairlady and executive director Sun Xinlei, holds 55.8% of the company’s issued shares, while Universal Health (Global) Investment Fund Management, wholly owned by Chen Xiaoyan, holds 16.7%, with additional smaller stakes held by Chen’s spouse and son.

The disclosure highlights that a very large majority of the company’s shares are effectively controlled by insiders and related parties, underscoring limited free float and potential liquidity constraints for minority investors. The board states that, apart from these identified parties, it does not know the identities or individual holdings of the other unnamed shareholders referenced by regulators, providing additional transparency but also reinforcing the concentrated ownership structure.

**More about Modern Chinese Medicine Group Co. Ltd.**

Modern Chinese Medicine Group Co., Ltd. is a Hong Kong-listed company in the healthcare sector, focusing on modernized traditional Chinese medicine products. The company is incorporated in the Cayman Islands and trades on the Main Board of the Stock Exchange of Hong Kong under stock code 1643.

**Average Trading Volume:** 3,222,203

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$1.86B

Find detailed analytics on 1643 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [01643.HK](https://longbridge.com/en/quote/01643.HK.md)

## Related News & Research

- [Modern Chinese Medicine Group Wins Waiver for Delay in Acquisition Circular](https://longbridge.com/en/news/285533413.md)
- [Modern Chinese Medicine Group to Modernise Articles of Association with Digital and Governance Upgrades](https://longbridge.com/en/news/284414771.md)
- [Atrandi Biosciences Expands Leadership Team to Accelerate Global Adoption of Capsule-Based Single-Cell Technology](https://longbridge.com/en/news/286912549.md)
- [Emirates breaks ground on $5.1bln engineering facility](https://longbridge.com/en/news/286774778.md)
- [Lipocine Showcases Phase 3 Data for Postpartum Depression](https://longbridge.com/en/news/286923466.md)